WISC011i-inGFPpuro
This cell line is a modified version of DF19-9-7T, engineered to contain CloverGFP and a puromycin resistance gene driven by the EF1a promoter. Ubiquitous and stable GFP expression clones were selected with puromycin selection. This cell line maintains constitutive expression of GFP.
|
Cell Type
|
Modified Human iPS |
|
Disease
|
None reported |
|
Genetic Modification Keyword
|
Reporter; Constitutive |
|
Sex
|
Male |
|
Genetically Related Cell Lines
|
|
|
Reprogramming Method
|
Non-Integrating (Episomal plasmid: pEP4EO2SET2K (OCT4/SOX2/LT/KLF4), pEP4EO2SEN2K (OCT4/SOX2/NANOG/KLF4), and pCEP4-M2L (MYC/LIN28) plasmids) |
|
Provider
|
University of Wisconsin - Dr. Igor Slukvin
|
|
dbGaP Data
|
|
|
hPSCReg ID
|
|
|
NIH Approval
|
|
|
Pub Med Abstract
|
|
|
Related Products
|
|
